search

Vaxcyte Inc (PCVX)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Vaxcyte (NASDAQ:PCVX) EVP Jim Wassil Sells 2,250 Shares of Stock
Nov 4, 2026

Vaxcyte (NASDAQ:PCVX) EVP Jim Wassil Sells 2,250 Shares of Stock

Vaxcyte EVP Jim Wassil recently sold 2,250 shares of Vaxcyte (NASDAQ:PCVX) stock for $137,025 under a pre-arranged trading plan, reducing his position by 1.52%. Following the sale, Wassil still holds 145,435 shares valued at over $8.8 million. The company reported adjusted earnings per share of -$1.99, surpassing analyst expectations, and has an average "Moderate Buy" rating with a target price of $110.50.
Company relevance
100.00%
Company sentiment
Neutral
Overall sentiment
Neutral
The Technical Signals Behind (PCVX) That Institutions Follow
Nov 2, 2026

The Technical Signals Behind (PCVX) That Institutions Follow

This article analyzes Vaxcyte Inc. (NASDAQ: PCVX) using AI models to identify technical signals and institutional trading strategies. Key findings include positive near-term sentiment within a long-term strength context, a mid-channel oscillation, and a significant risk-reward short setup. The report details specific position trading, momentum breakout, and risk hedging strategies based on multi-timeframe signal analysis.
Company relevance
100.00%
Company sentiment
Somewhat-Bullish
Overall sentiment
Somewhat-Bullish